# 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Amyotrophic Lateral Sclerosis (REPAIR-ALS)

> **NCT03843710** · PHASE2 · WITHDRAWN · sponsor: **Clene Nanomedicine**

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Gold Nanocrystals

## Key facts

- **NCT ID:** NCT03843710
- **Lead sponsor:** Clene Nanomedicine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-03
- **Primary completion:** 2022-02
- **Final completion:** 2022-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study execution discontinued at this time.
- **Last updated:** 2023-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03843710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03843710, "31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Amyotrophic Lateral Sclerosis (REPAIR-ALS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03843710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*